Corestreet Logo

Enliven Therapeutics Inc. (ELVN) Insider Trading

Total insider buys:
  • $0.00
Total insider sells:
  • $60,870,218.96
Most recent insider trade:
  • Sept. 23, 2025
Most active insider trader:
  • Benjamin Hohl
Trader NameDateTitleAmountPriceTypeTotal Value
Sept. 23, 2025CEO2,800$20.03Sell$56,084.00
Sept. 23, 2025Insider1,500$20.03Sell$30,045.00
Sept. 19, 2025Insider7,000$19.39Sell$135,730.00
Sept. 19, 2025CEO1,000$20.25Sell$20,250.00
Sept. 17, 2025CEO5,000$19.09Sell$95,450.00
Sept. 8, 2025COO6,667$20.24Sell$134,940.08
Aug. 27, 2025CFO3,250$20.63Sell$67,047.50
Aug. 21, 2025Insider7,500$20.01Sell$150,075.00
Aug. 19, 2025CEO590$20.00Sell$11,800.00
Aug. 19, 2025Insider5,000$19.62Sell$98,100.00
Aug. 18, 2025CEO10,393$20.02Sell$208,067.86
Aug. 7, 2025COO6,667$18.24Sell$121,606.08
July 28, 2025CFO3,250$20.46Sell$66,495.00
July 21, 2025Insider12,500$22.29Sell$278,625.00
July 17, 2025CEO12,500$22.52Sell$281,500.00
July 10, 2025CFO1,000$22.66Sell$22,660.00
July 7, 2025COO6,667$19.79Sell$131,939.93
June 27, 2025CFO3,250$20.91Sell$67,957.50
June 20, 2025Insider12,500$21.40Sell$267,500.00
June 17, 2025CEO12,500$22.18Sell$277,250.00
June 9, 2025COO6,667$20.34Sell$135,606.78
June 3, 2025Insider7,500$20.03Sell$150,225.00
June 3, 2025CEO7,500$20.05Sell$150,375.00
May 27, 2025CFO3,250$16.18Sell$52,585.00
May 19, 2025Insider5,000$16.31Sell$81,550.00
May 19, 2025CEO5,000$16.49Sell$82,450.00
May 7, 2025COO6,667$18.39Sell$122,606.13
May 1, 2025CEO5,330$20.08Sell$107,026.40
May 1, 2025Insider5,030$20.07Sell$100,952.10
April 28, 2025CFO3,250$18.69Sell$60,742.50
April 21, 2025Insider5,000$16.07Sell$80,350.00
April 17, 2025CEO5,000$16.42Sell$82,100.00
April 7, 2025COO6,667$18.04Sell$120,272.68
March 27, 2025CFO3,250$21.33Sell$69,322.50
March 24, 2025CFO1,000$22.50Sell$22,500.00
March 19, 2025Insider12,500$20.61Sell$257,625.00
March 17, 2025CEO12,500$20.83Sell$260,375.00
March 7, 2025COO6,667$21.44Sell$142,940.48
Feb. 27, 2025CFO3,250$20.41Sell$66,332.50
Feb. 7, 2025COO6,667$21.93Sell$146,207.31
Feb. 5, 2025CFO1,000$22.52Sell$22,520.00
Jan. 27, 2025CFO3,250$21.59Sell$70,167.50
Jan. 7, 2025COO21,700$24.18Sell$524,706.00
Jan. 3, 2025CFO1,000$25.04Sell$25,040.00
Dec. 30, 2024CFO900$22.51Sell$20,259.00
Dec. 27, 2024CFO3,350$22.15Sell$74,202.50
Nov. 27, 2024CFO5,250$24.89Sell$130,672.50
Oct. 28, 2024CFO6,250$28.56Sell$178,500.00
Oct. 18, 2024COO716$30.00Sell$21,480.00
Oct. 18, 2024Director817$30.00Sell$24,510.00
First«1 of 3»Last

  • Insiders are selling Enliven Therapeutics Inc. stock.

  • The insider traders at Enliven Therapeutics Inc. are: Benjamin Hohl, Samuel Kintz, Anish Patel, Joseph P Lyssikatos, Richard A Heyman, Joseph P. Lyssikatos, Rahul D Ballal, 5Am Partners Vi, Llc, and Rishi Gupta

  • The most active insider trader at Enliven Therapeutics Inc. is Benjamin Hohl with 36 trades.

  • Rishi Gupta has sold the most Enliven Therapeutics Inc. stock with a total value of $45,754,524.00.

  • The most recent insider trade for Enliven Therapeutics Inc. was on Sept. 23, 2025.

  • The single biggest insider sell for Enliven Therapeutics Inc. was from Rishi Gupta with a total value of $22,877,262.00 on May 16, 2024.